Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intrinsic Biosciences
California, United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Intrinsic LifeSciences developed the world’s first validated hepcidin assay, enabling accurate measurement of this key hormone in human and animal models. Their ELISA kits are used globally in research and clinical settings to diagnose and monitor iron-related disorders. The company is developing the first FDA-approved blood test for hepcidin[1][2].
- Therapeutic areas
- Metabolic DisordersHematology
- Modalities
- In vitro diagnostics (ELISA kits)
- Industry
- Protein Biomarker Diagnostics
Beyond the preview
Go deeper on Intrinsic Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Intrinsic Biosciences.